Clinical Trials in Philadelphia

Showing 14461-14480 of 20,349 trials

Cardiovascular Improvements With MV ASV Therapy in Heart Failure

NCT01953874

The aim of the study is to compare the effects of MV targeted ASV in addition to optimized medical therapy versus optimized medical therapy alone at 6 months in patients with acute decompensated HF. The study will also assess changes in functional parameters, biomarkers, quality of life (QOL), and sleep.

Acute Decompensated Heart FailureSleep Disordered Breathing

ResMed126 participantsStarted Dec 2013

Huntsville, Alabama, United States • Los Angeles, California, United States • Denver, Colorado, United States +12 more locations

COMPLETEDPhase 3< 1 mile

Treatment of Thrombocytopenia in Patients With Chronic Liver DiseaseUndergoing an Elective Procedure

NCT01972529

This is a global, multicenter, randomized, double-blind, placebo-controlled, parallel group study using avatrombopag to treat adults with thrombocytopenia associated with liver disease. The study will evaluate avatrombopag in the treatment of thrombocytopenia associated with liver disease prior to an elective procedure to reduce the need for platelet transfusions or any rescue procedure for bleeding due to procedural and post-procedural bleeding complications. Participants will be enrolled into 2 cohorts according to mean baseline platelet count and, within each baseline platelet count cohort will be further stratified by risk of bleeding associated with the elective procedure (low, moderate, or high) and hepatocellular carcinoma (HCC) status (Yes or No).

Thrombocytopenia Associated With Liver Disease

Eisai Inc.231 participantsStarted Feb 2014

Lancaster, California, United States • Long Beach, California, United States • Los Angeles, California, United States +106 more locations

Cardiovascular Improvements With MV ASV Therapy in Heart Failure

Treatment of Thrombocytopenia in Patients With Chronic Liver DiseaseUndergoing an Elective Procedure

Find Trials by Condition in Philadelphia

A Phase 1 Study Evaluating CB-5083 in Subjects With Advanced Solid Tumors

Using a Motivational Interviewing (MI) Informed Text Messaging Program to Lower Blood Sugar in Diabetic Patients.

Telotristat Etiprate for Carcinoid Syndrome Therapy

Irinotecan-Eluting Beads in Treating Patients With Refractory Metastatic Colon or Rectal Cancer That Has Spread to the Liver

Extension Study Of Subjects From Study A3921030 For The Prevention Of Acute Rejection In Kidney Transplant Patients

Rhodiola Rosea Therapy of Major Depressive Disorder

Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)

Phase I Study of CUDC-101 With Cisplatin and Radiation in Subjects With Head & Neck Cancer

Lactated Ringers With or Without Rectal Indomethacin to Prevent Post-ERCP Pancreatitis

Trebananib in Treating Patients With Persistent or Recurrent Endometrial Cancer

Nutritional Supplementation With Agmatine Sulfate During Small Fiber Neuropathy

Study of Safety, Tolerability, and Efficacy of Secukinumab in Subjects With Moderate to Severe Palmoplantar Psoriasis

Abatacept for Treating Adults With Giant Cell Arteritis and Takayasu's Arteritis

Extension Study of Gelesis100 on Body Weight

Deflazacort Expanded Access Program for Children, Adolescents and Adults With Duchenne Muscular Dystrophy

A Phase 1 Study Evaluating CB-5083 in Subjects With Lymphoid Hematological Malignancies

Dropless vs. Standard Drops Contralateral Eye Study

Phase 2 Trial of AEZS-108 in Chemotherapy Refractory in Triple Negative Breast Cancer